Symphony Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$1.18M Buy
+11,592
New +$1.04M 0.38% 36
2016
Q2
Sell
-14,416
Closed -$244K 370
2016
Q1
$244K Sell
14,416
-212
-1% -$3.54K 0.03% 340
2015
Q4
$300K Sell
14,628
-5,596
-28% -$116K 0.03% 367
2015
Q3
$434K Buy
20,224
+9,716
+92% +$217K 0.05% 339
2015
Q2
$210K Sell
10,508
-10,624
-50% -$187K 0.03% 388
2015
Q1
$329K Buy
21,132
+3,108
+17% +$47K 0.04% 404
2014
Q4
$248K Sell
18,024
-6,644
-27% -$81.3K 0.03% 362
2014
Q3
$246K Sell
24,668
-75,344
-75% -$770K 0.03% 354
2014
Q2
$992K Buy
100,012
+24,336
+32% +$216K 0.1% 222
2014
Q1
$783K Buy
75,676
+37,288
+97% +$385K 0.07% 235
2013
Q4
$340K Sell
38,388
-98,616
-72% -$780K 0.02% 357
2013
Q3
$966K Sell
137,004
-39,256
-22% -$249K 0.1% 191
2013
Q2
$989K Buy
+176,260
New +$844K 0.1% 192

Other funds holding DXCM

Symphony Asset Management's DXCM Position: Q2 2020 in Review

Symphony Asset Management opened a new position in DexCom (DXCM) in Q2 2020: 11,592 shares worth $1.18M. The stake represents 0.38% of the portfolio and ranks #36 among its holdings. This is a return to the name: Symphony Asset Management previously reported a position in DXCM as recently as Q1 2016.

Symphony Asset Management first reported a position in DXCM in Q2 2013 and has held it in 13 quarters since. 723 funds tracked by Wall St. Rank hold DXCM as of Q2 2020.

  • Symphony Asset Management held 11,592 shares of DexCom worth $1.18M as of Q2 2020.
  • DexCom was a new Symphony Asset Management position in Q2 2020.
  • DexCom made up 0.38% of Symphony Asset Management's portfolio in Q2 2020, its #36 holding.
  • Symphony Asset Management first reported a position in DexCom in Q2 2013 and has held it in 13 quarters since.
  • 723 funds tracked by Wall St. Rank held DexCom as of Q2 2020.

Based on Symphony Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.